The Role of Nomogram Based on the Combination of Ultrasound Parameters and Clinical Indicators in the Degree of Pathological Remission of Breast Cancer

Table 2

Comparative analysis of differences in ultrasound and serum indexes between the NMHR group and MHR group.

Index	Before therapy				After treatment
	NMHR (n = 93)		MHR (n = 54)		NMHR (n = 93)	MHR (n = 54)
Form	Rule	3 (3.2)	1 (1.9)	0.622	5 (5.4)	3 (5.8)	1.000
	Irregular	90 (96.8)	53 (98.1)		88 (94.6)	49 (94.2)
Direction	Level	83 (89.2)	51 (94.4)	0.442	85 (91.4)	46 (92.0)	1.000
	Vertical bit	10 (10.8)	3 (5.6)		8 (8.6)	4 (8.0)
Strong echo halo	None	59 (63.4)	18 (33.3)	<0.001	66 (71.0)	52 (96.3)	<0.001
	Have	34 (36.6)	36 (66.7)		27 (29.0)	2 (3.7)
Calcification	None	43 (46.2)	23 (42.6)	0.668	22 (23.7)	16 (32.0)	0.281
	Have	50 (53.8)	31 (57.4)		71 (76.3)	34 (68.0)
Boundary	Clear	53 (57.0)	22 (40.7)	0.057	22 (23.7)	7 (13.0)	0.116
	Not clear	40 (43.0)	32 (59.3)		71 (76.3)	47 (87.0)
Echo	Very low	16 (17.2)	5 (9.4)	0.412			0.662
	Low	74 (79.6)	44 (83.0)		69 (75.0)	35 (70.0)
	Mix	2 (2.2)	3 (5.7)		3 (3.3)	1 (2.0)
	Wait for an echo	1 (1.1)	1 (1.9)		20 (21.7)	14 (28.0)
Rear echo attenuation	None	64 (68.8)	47 (87.0)	0.013	49 (52.7)	32 (59.3)	0.440
	Have	29 (31.2)	7 (13.0)		44 (47.3)	22 (40.7)
Adler	Level 0	0 (0.0)	2 (3.7)	<0.001	10 (10.8)	38 (70.4)	<0.001
	Level 1	13 (14.0)	29 (53.7)		27 (29.0)	14 (25.9)
	Level 2	46 (49.5)	22 (40.7)		38 (40.9)	2 (3.7)
	Level 3	34 (36.6)	1 (1.9)		18 (19.4)	0 (0.0)
Diameter	3.60 (2.40,5.05)		3.00 (2.08,4.80)	0.164	2.30 (1.40,4.00)	1.00 (0.70,1.80)	<0.001
RI	0.74 (0.68,0.80)		0.62 (0.60,0.68)	<0.001	0.68 (0.61,0.76)	0.00 (0.00,0.51)	<0.001
CEA	2.71 (1.68,5.71)		2.34 (1.41,5.18)	0.436	2.60 (1.60,3.81)	1.85 (1.28,3.07)	0.003
CA125	16.23 (10.74,25.22)		14.11 (10.29,24.74)	0.674	14.41 (10.67,19.52)	13.97 (10.19,17.27)	0.210
CA153	18.49 (12.22,28.50)		12.70 (7.95,21.83)	0.003	20.47 (15.73,28.55)	15.65 (12.48,23.61)	0.006
CA50	5.40 (2.61,11.00)		4.95 (2.70,9.65)	0.629	7.35 (4.30,11.25)	6.80 (3.90,11.20)	0.591